BRAF and melanoma: The most prevalent mutation is BRAF V600E, a valine-to-glutamate substitution in the kinase domain, leading to a constant protein kinase activation, including MEK/ERK signaling cascade, resulting in melanocyte hyperproliferation and contributing to melanoma development [8].